Varivax vaccine with diluents
Ended Awarded
- Contract number
- SPE2DB25FEBHE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,321
Award facts
- Contract value 100% obligated
- $10,321.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $10,321.10 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of May 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health System. The company maintains an extensive portfolio of federal contracts through the Defense Logistics Agency, supplying a comprehensive range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The Varivax vaccine delivery order represents a routine pharmaceutical procurement action within AmerisourceBergen's established role as a primary vendor for federal medical supply chains, demonstrating the company's capacity to fulfill both large-scale IDC requirements and specific delivery order requests across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FEBHE?
SPE2DB25FEBHE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 22, 2025.
How much is contract SPE2DB25FEBHE worth?
The government has obligated $10,321 on SPE2DB25FEBHE.
Is contract SPE2DB25FEBHE an order under another contract?
Yes. SPE2DB25FEBHE is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEBHE competed?
The extent of competition for SPE2DB25FEBHE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award